Headlines about PhotoMedex (NASDAQ:PHMD) have trended somewhat positive recently, Accern reports. The research group scores the sentiment of media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. PhotoMedex earned a media sentiment score of 0.21 on Accern’s scale. Accern also assigned news headlines about the medical equipment provider an impact score of 43.8038807759118 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Separately, ValuEngine upgraded shares of PhotoMedex from a “strong sell” rating to a “sell” rating in a research note on Friday, June 2nd.

PhotoMedex (NASDAQ PHMD) traded down 1.96% during mid-day trading on Friday, hitting $1.00. 500 shares of the company were exchanged. The firm has a 50 day moving average price of $1.00 and a 200 day moving average price of $1.35. The stock’s market cap is $6.16 million. PhotoMedex has a 12 month low of $0.71 and a 12 month high of $5.60.

COPYRIGHT VIOLATION WARNING: This article was reported by Daily Political and is the sole property of of Daily Political. If you are viewing this article on another domain, it was copied illegally and reposted in violation of international copyright and trademark law. The correct version of this article can be accessed at https://www.dailypolitical.com/2017/09/08/somewhat-positive-media-coverage-somewhat-unlikely-to-impact-photomedex-phmd-stock-price.html.

PhotoMedex Company Profile

PhotoMedex, Inc is a global health products and services company providing integrated disease management and solutions to dermatologists, professional aestheticians and consumers. The Company provides products and services that address skin diseases and conditions, including acne and photo damage. The Company operates through three business segments: Consumer segment, Physician Recurring segment and Professional segment.

Insider Buying and Selling by Quarter for PhotoMedex (NASDAQ:PHMD)

Receive News & Ratings for PhotoMedex Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PhotoMedex Inc and related companies with MarketBeat.com's FREE daily email newsletter.